Magnetic Resonance Imaging Biomarkers of Bone and Soft Tissue Tumors

Research output: Contribution to journalArticlepeer-review

Abstract

Magnetic resonance imaging (MRI) is essential in the management of musculoskeletal (MSK) tumors. This review delves into the diverse MRI modalities, focusing on anatomical, functional, and metabolic sequences that provide essential biomarkers for tumor detection, characterization, disease extent determination, and assessment of treatment response. MRI's multimodal capabilities offer a range of biomarkers that enhance MSK tumor evaluation, aiding in better patient management.

Original languageEnglish (US)
Pages (from-to)39-48
Number of pages10
JournalSeminars in Musculoskeletal Radiology
Volume28
Issue number1
DOIs
StatePublished - Feb 8 2024

Keywords

  • biomarker
  • bone tumor
  • magnetic resonance imaging
  • sarcoma
  • soft tissue tumor

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Magnetic Resonance Imaging Biomarkers of Bone and Soft Tissue Tumors'. Together they form a unique fingerprint.

Cite this